For this purpose, we used the AT8 anti-Tau antibody, a reagent highlighted in a consensus meeting for the diagnosis of FTD [34] and also used in the characterization of Tau strains in inoculation experiments [35]). Here, MAPT is linked to frontotemporal dementia.